Searchable abstracts of presentations at key conferences in endocrinology

ea0029p351 | Clinical case reports - Pituitary/Adrenal | ICEECE2012

Familial central diabetes insipidus due to a novel mutation in exon 3 of the arginine vasopressin gene

Ritter M. , Gross U. , Feldkamp J. , Hoppner W. , Schulte H.

Neurohypophyseal diabetes insipidus (DI) is said to be caused by familial forms in about 5% of cases1. Hereditary transmission is autosomal dominant in most families and is caused by a mutation in the arginine vasopressin (AVP) gene on chromosome 20p13, which encodes for a large precursor hormone.A 19-years old otherwise healthy patient seeked endocrine care for an inadequately treated DI. He reported about an undoubtful disease history with a...

ea0029p962 | Female Reproduction | ICEECE2012

Impaired beta cell function in Chinese women with polycystic ovary syndrome

Tao T. , Li S. , Liu W. , Zhao A. , Ning G.

Objective: The role of pancreatic insulin secretion in Chinese women with polycystic ovary syndrome (PCOS) is not clear. To evaluate insulin sensitivity (IS) and β-cell function in lean and obese women with PCOS, either separately or by using an disposition index (DI).Methods: Cross-sectional study involving 137 Chinese women with PCOS and 123 normal women were examined by anthropometry, lipid profile, sex hormone, high-sensitivity C-reactive protei...

ea0029p1425 | Pituitary Clinical | ICEECE2012

Effects of medical treatment on proliferation parameters MIB-1 and topoisomerase-IIα in GH secreting pituitary adenomas

Schlaffer S. , Lin F. , Saeger W. , Buchfelder M.

Introduction: In this present study, we assessed the effects of the last preoperative medical treatment (dopamine-agonists, somatostatin-analogous and GH receptor antagonists) on the proliferation parameters Ki-67 and Topoisomerase-IIα in pituitary adenomas of patients with acromegaly.Material and methods:: We retrospectively studied the clinical characteristics, neuroimaging, histology and immuno-histochemistry (Ki-67 and topoisomerase-IIα lab...

ea0029p1477 | Pituitary Clinical | ICEECE2012

Cushing’s disease: prospective assessment of factors influencing the efficacy of transsphenoidal surgery

Witek P , Zielinski G , Szamotulska K , Zgliczynski W

Introduction: Assessment of the efficacy of surgical treatment for Cushing’s disease (CD) is one of the biggest challenges in contemporary endocrinology. The aim of this study was prospective evaluation of factors influencing the result of transsphenoidal surgery for CD.Methods: The study population consisted of 36 consecutive patients with CD hospitalized in the Department of Endocrinology from 2005 to 2009 and operated on using the same surgical p...

ea0029p1644 | Thyroid (non-cancer) | ICEECE2012

Vitamin D deficiency is not associated with thyroid autoimmunity

Effraimidis G. , Badenhoop K. , Tijssen J. , Wiersinga W.

Context: Vitamin D deficiency has been identified as a risk factor for a number of autoimmune diseases including type 1 diabetes and multiple sclerosis.Objective: We hypothesized that low levels of vitamin D are related to the early stages of autoimmune thyroid disease.Design: Two case-control studies were performed. Study A: cases were subjects from the Amsterdam AITD cohort (euthyroid women who had 1st or 2nd degree relatives wit...

ea0026oc4.6 | Diabetes/Thyroid | ECE2011

No causal relationship between Yersinia enterocolitica infection and autoimmune thyroid disease: evidence from a prospective study

Effraimidis G , Tijssen J G P , Wiersinga W M

Objective: To evaluate prospectively the relationship between Yersinia Enterocolitica (YE) infection and the development of overt autoimmune hypo- or hyperthyroidism (study A) and the de novo occurrence of thyroid antibodies (study B).Subjects and methods: Prospective cohort study of 790 euthyroid women who were 1st or 2nd degree relatives of AITD patients. Follow-up was 5 years, with annual assessments.Study A. Nested case&...

ea0026p228 | Pituitary | ECE2011

Non-traditional effects of GH: a survival factor for retinal ganglion cells

Harvey S , Lin W , Parker E , Sanders E

Introduction: GH and its receptor (GHR) are expressed in retinal ganglion cells (RGCs) in the eyes of chick embryos, and in mouse, rat and human eyes. Within the retina, exogenous GH has neuroprotective actions, mediated by caspase-dependent and caspase-independent mechanisms that may also be dependent upon IGF1 signaling. Conversely, the immunoneutralization of endogenous GH promotes apoptosis in the retina and in isolated RCGs. The functional relevance of retinal GH was furt...

ea0024p24 | (1) | BSPED2010

Short stature with deletion of chromosome 15q and duplication of 16q (q26.3:q23.1)

Ho S , Vasudevan P , Madira W , Greening J

Introduction: The IGF1-receptor (IGF1R) gene is located on the distal long arm of chromosome 15 (bands q26.3). Short stature due to mutation or deletion of IGF1R gene is rare. Mutation of this gene is better known compared to deletion as a cause of growth hormone resistance. We report a girl with pre and postnatal growth failure with chromosome 15q deletion and 16q duplication.Case report: Our patient was born at term weighing 2.7 kg (2nd centile). She w...

ea0021p333 | Steroids | SFEBES2009

Reference range data on androsterone glucuronide in healthy male and female volunteers and clinical uses of the assay

Adaway Joanne , Miller Adrian , Wu F C W , Keevil Brian

Androsterone glucuronide (ADG) is a major metabolite of the androgen dihydrotestosterone and has also been shown to arise from the intracrine conversion of other adrenal androgens such as androstenedione and androsterone. ADG has been shown to be raised in some women with clinical signs of hyperandrogenism such as acne and hirsutism, even when levels of androgens, e.g. testosterone or DHEA-S are normal. This indicates that raised ADG levels may be an early indication of hypera...

ea0021p369 | Thyroid | SFEBES2009

A difficult case of very aggressive thyroid eye disease

Balaguruswamy Saravanan , Chandrasekara W M H S , McNulty S

Thyroid eye disease (TED) is clinically evident in 25–50% of patients with Graves’ disease and 3–5% of cases develop severe eye disease. We present a case of very aggressive TED.A 46-year-old gentleman developed graves thyrotoxicosis and was blocked and replaced with carbimazole and thyroxine. He continued to smoke 20 cigarettes/day despite several advises.He developed marked exophthalmos (L>R), chemosis, with re...